Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RGEN stock: Repligen Corporation

Current Rating
Hold/Sell

Previous Rating:

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$39.26
Market Cap
1.26B
Sector
Health Care
Div. Growth
-
P/E
107.6
P/B
7.38
P/S
11.91
Dividend %
-
P/CF
18.4
P/FCF
403.4
Op. Cash Flow
7.5K
FCF
0.0
Op. Margin
15.30%
Net Margin
11.20%
ROE
7.40%
ROI
6.00%
ROA
4.70%
EPS Growth
22.00%
Current Ratio
8.7
Debt/Equity
56.50%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Chembio Diagnostics Inc (CEMI) $6.80 - - 76.3M Strong Buy
BioLife Solutions Inc (BLFS) $2.28 - - 26.3M Strong Buy
Milestone Scientific Inc. (MLSS) $1.40 - - 38.3M Strong Buy
MGC Diagnostics Corp (MGCD) $8.21 - - 37.6M Strong Buy
Bioanalytical Systems, Inc. (BASI) $1.63 - - 10.1M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More